Importadora y Manufacturera Burluart S.A.
⚠️ High Risk
FEI: 3003723705 • Tultitlan • MEXICO
FEI Number
3003723705
Location
Tultitlan
Country
MEXICOAddress
Geranios No. 9, San Francisco Chilpan, Tultitlan, , Mexico
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/14/2025 | 54AFY04VITAMIN B6 (PYRIDOXINE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/24/2025 | 54AGY02VITAMIN B1 (THIAMINE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/1/2025 | 54AGL02VITAMIN B1 (THIAMINE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/1/2024 | 64LDK19DEXAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/27/2022 | 66VIA99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 1/17/2018 | 60WDA01ALBENDAZOLE (ANTHELMINTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/28/2017 | 62LCB45EFLORNITHINE HYDROCHLORIDE (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/16/2017 | 62GDA99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/11/2017 | 62GDA18DICLOFENAC SODIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/11/2017 | 60SDA25RANITIDINE HYDROCHLORIDE (ANTACID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/24/2017 | 60LCA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/26/2017 | 62GDA18DICLOFENAC SODIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/23/2017 | 64LCA56PREDNISONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/5/2017 | 60SCA25RANITIDINE HYDROCHLORIDE (ANTACID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/24/2017 | 61KCB99ANTI-CHOLINERGIC, N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 2/10/2017 | 62GDC18DICLOFENAC SODIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/30/2016 | 66SCA49PENTOXIFYLLINE (VASODILATOR) | New Orleans District Office (NOL-DO) | |
| 3/16/2015 | 80KZHINTRODUCER, SYRINGE NEEDLE | New Orleans District Office (NOL-DO) | |
| 10/16/2008 | 64LIY19DEXAMETHASONE (GLUCOCORTICOID) | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Importadora y Manufacturera Burluart S.A.'s FDA import refusal history?
Importadora y Manufacturera Burluart S.A. (FEI: 3003723705) has 19 FDA import refusal record(s) in our database, spanning from 10/16/2008 to 11/14/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Importadora y Manufacturera Burluart S.A.'s FEI number is 3003723705.
What types of violations has Importadora y Manufacturera Burluart S.A. received?
Importadora y Manufacturera Burluart S.A. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Importadora y Manufacturera Burluart S.A. come from?
All FDA import refusal data for Importadora y Manufacturera Burluart S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.